Sarepta Therapeutics experienced one of its most severe trading sessions in recent history, with shares collapsing by more than 33%....

The biotechnology sector is watching closely as Kura Oncology approaches a pivotal moment in its corporate history. With the FDA's...

Cadence Design Systems finds itself at a critical juncture following its latest earnings release. While the company delivered exceptional quarterly...

Texas Pacific Land Corporation has announced a series of significant strategic and financial developments for the third quarter of 2025,...

Chewy Inc., the prominent online pet supplies retailer, finds itself at a pivotal crossroads. The company's shares continue to struggle...

While AT&T shares continue to face significant downward pressure, a notable divergence is emerging between price action and institutional behavior....

The biotechnology firm Cytokinetics is navigating a period of extreme uncertainty, with two pivotal December events poised to determine its...

The curtain has closed on Focus Financial Partners' time as a public market darling. In a revealing presentation at the...

Hovnanian Enterprises shares are presenting investors with a complex puzzle as institutional, insider, and analyst activities paint a contradictory picture...

The investment community is holding its breath as Anavex Life Sciences approaches a pivotal moment that will determine its future...